Dong et al. showed that overexpression of H2AFZ is associated with poor prognosis and tumor malignancy in HCC patients and that its overexpression is regulated by TP53 mutations, which leads to the development of a rapidly proliferative phenotype in HCC cells [54]. This evidence concerns the gene TP53 and hepatocellular carcinoma.